Etodolac Tablet, Extended Release
Product Images NDC 63187-793

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 63187-793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Etodolac 01)

Chemical structure of etodolac, showing its molecular framework with distinct functional groups including aromatic and heterocyclic rings, consistent with its depiction as an NSAID molecule.*

FDA Label Image

63187-793-30 (Etodolac 02)

Etodolac 400 mg extended-release tablets packaging label from Proficient Rx LP. The label states #30 tablets, oral route, with dosage form and strength specified as 400 mg ER tablets. It includes instructions to dispense with an accompanying Medication Guide and storage conditions (20°-25°C). The product ID and manufacturer information (Taro Pharmaceutical Industries Ltd.) are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.